Parenteral Drugs Large small volume parenteral defined as formulation intended for injection into skin, veins, artery muscles or other external boundary tissue, rather than through the alimentary canal, so that formulation directly reach to systemic circulation cause the onset action. Intravenous IV , subcutaneous SC , and intramuscular IM route are the mostly commonly used parenteral routes, but there are also less frequent used routes includes intradermal, intra arterial. Generally, are classified into large volume parenteral and small volume depending on the package size if more than 100 ml termed as large volume parenteral and rest small volume parenteral except biological. In 21st, Century, pharmaceutical manufacturing sector geared up to deliver the medicine at faster rate with excellence performance. With help of automation and sophisticated analytical techniques, thus industries are capable to achieve significant to quality controlled formulation. Currently, world wide efforts have been made to ensure the practice good manufacturing practice and good laboratory practices for the uplifting of pharmaceuticals. In process quality control tests are carried out with a motive to eliminate error from each step in manufacturing and maintain the quality of the finished products with the official standards as specified in the pharmacopoeias. Present review it is clearly depicted that various pharmacopoeias guides different quality parameters but the major intention is to produce effective good quality products and implement the good manufacturing practices. Shubham Kumar | Dr. Rajiv K. Tonk | Dr. Prabodh C. Sharma "Some Quality Control Analysis Parameters for Parenteral Formulations" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-5 | Issue-4 , June 2021, URL: https://www.ijtsrd.compapers/ijtsrd42432.pdf Paper URL: https://www.ijtsrd.compharmacy/other/42432/some-quality-control-analysis-parameters-for-parenteral-formulations/shubham-kumar
International Journal of Trend in Scientific Research and Development (IJTSRD)
Volume 5 Issue 4, May-June 2021 Available Online: www.ijtsrd.com e-ISSN: 2456 – 6470
@ IJTSRD | Unique Paper ID – IJTSRD42432 | Volume – 5 | Issue – 4 | May-June 2021
Page 944
Some Quality Control Analysis
Parameters for Parenteral Formulations
Shubham Kumar1, Dr. Rajiv K. Tonk2, Dr. Prabodh C. Sharma3
1M.Pharm, 2Professor, 3Associate Professor,
1, 2, 3Department of Pharmaceutical Chemistry (Pharmaceutical Analysis),
SPS Delhi Pharmaceutical Sciences and Research University, Saket New Delhi, India
ABSTRACT
Parenteral Drugs (Large/small volume parenteral) defined as formulation
intended for injection into skin, veins, artery muscles or other external
boundary tissue, rather than through the alimentary canal, so that formulation
directly reach to systemic circulation cause the onset action. Intravenous (IV),
subcutaneous (SC), and intramuscular (IM) route are the mostly commonly
used parenteral routes, but there are also less frequent used routes includes
intradermal, intra-arterial. Generally, are classified into large volume
parenteral and small volume depending on the package size if more than 100
ml termed as large volume parenteral and rest small volume parenteral except
biological. In 21st, Century, pharmaceutical manufacturing sector geared up to
deliver the medicine at faster rate with excellence performance. With help of
automation and sophisticated analytical techniques, thus industries are
capable to achieve significant to quality-controlled formulation. Currently,
world-wide efforts have been made to ensure the practice good manufacturing
practice and good laboratory practices for the uplifting of pharmaceuticals. In-
process quality control tests are carried out with a motive to eliminate error
from each step-in manufacturing and maintain the quality of the finished
products with the official standards as specified in the pharmacopoeias.
Present review it is clearly d